News By Tag
* Antiviral supplements
* Chronic Diseases
* Latent Viruses
* More Tags...
News By Place
Gene-Eden VIR-101 Back in Stock, Available Now
polyDNA has received its next stock of Gene-Eden, formula VIR-101. If you care to order the product, service will be prompt and affordable. Gene-Eden formula VIR-101 is available for those who order today for $34.99.
From Dr. Polansky’s study, Gene Eden was developed. Gene Eden is an anti-viral supplement with five natural ingredients:
Gene-Eden has been true to its word. Since its manufacture it has ceaselessly provided protection and energy for the immune system for thousands of its users. Testimonies and reviews not only come from customers but from many other scientists and doctors as well, who have given positive feedback and comments about the use of Gene-Eden during the first stages of viral infection and in the maintenance period. Improvements and prevention of diseases caused by viruses like Hepatitis Virus (Hepatitis C Virus, Hep C, HCV, Hepatitis B Virus, Hep B, HBV, etc), Human Papilloma Virus (HPV), Epstein-Barr Virus (EBV), Herpes Simplex Virus (HSV), Cytomegalovirus (CMV) and Varicella Zoster Virus (VZV) have been experienced by customers worldwide. Customers also testify to the continuous energy, relief from pain, improvement on sleep patterns as well as glucose and cholesterol levels, and overall better health. Many recommendations have been given for its continued use. Gene-Eden is hard to compare to any other product of its kind. These acknowledgements and revelations are all over Amazon and other review sites on the internet.
Because of the positive response from customers and scientists, continuous studies about its effectiveness against other forms of illness and disease are still being conducted. Gene-Eden is now back in stock, available at www.gene-eden.com and at www.amazon.com.
The Center for the Biology of Chronic Disease (CBCD, http://www.cbcd.net) is a research center recognized by the IRS as a 501(c)(3) non-for-profit organization. The mission of the CBCD is to advance the research on the biology of chronic diseases, and to accelerate the discovery of treatments for these diseases.
# # #
polyDNA, a biotechnology company, developed and markets Gene-Eden, an antiviral dietary supplement that targets the most common chronic viruses, including EBV, CMV, HSV, VZV, HBV, HCV, and HPV.